About CAPTURA BIOPHARMA INC.
Captura Biopharma is developing C2E2, an oral solution designed to eliminate harmful radioactive materials and heavy metals from the body, offering an accessible treatment option for large-scale exposure scenarios.
Development of C2E2, an oral decorporation agent for removing radioactive materials and heavy metalsPioneering bioavailability of established agents like Ca-DTPA and Zn-DTPAFocus on creating accessible treatment options for mass casualties from nuclear incidents or heavy metal toxicity
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CAPTURA BIOPHARMA INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.